Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,935 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00774878 | Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer | terminated | Phase 2 | 18 | SanofiINDUSTRY | 3 | Mar 3, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT01076751 | Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients(PORTREAT) | terminated | — | 82 | SanofiINDUSTRY | 5 | Feb 14, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00242762 | ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer | completed | Phase 2 | 36 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00082277 | Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer(SABRE) | completed | Phase 4 | 237 | AstraZenecaINDUSTRY | 8 | Jan 26, 2011 | clinicaltrials |
| NCT00329004 | A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 89 | Bristol-Myers SquibbINDUSTRY | 4 | Jan 25, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00661609 | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 5 | Jan 12, 2011 | clinicaltrials |
| NCT01274806 | Take-Care Program: Effectiveness of a Physical Therapy Program on Cancer Related Symptoms(TAKE-CARE) | completed | N/A | 78 | Instituto de Salud Carlos IIIOTHER_GOV | 1 | Jan 12, 2011 | clinicaltrials |
| NCT00388635 | Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. | completed | Phase 1 / Phase 2 | 60 | PETHEMA FoundationOTHER | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | Eli Lilly and CompanyINDUSTRY | 4 | Dec 28, 2010 | clinicaltrials |
| NCT00647075 | Yunzhi as Dietary Supplement in Breast Cancer(YUNZHI-BC) | unknown | Phase 4 | 60 | Hospital Clinic of BarcelonaOTHER | 1 | Dec 15, 2010 | clinicaltrials |
| NCT00673205 | (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer(Capri) | completed | Phase 3 | 3,588 | AstraZenecaINDUSTRY | 16 | Dec 10, 2010 | clinicaltrials |
| NCT00705822 | Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer(PROSTATA) | terminated | Phase 3 | 54 | SanofiINDUSTRY | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00374868 | Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable) | completed | Phase 1 / Phase 2 | 59 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 4, 2010 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | completed | Phase 3 | 321 | PfizerINDUSTRY | 16 | Sep 28, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00831909 | Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN(EPICLIN) | completed | — | 3,513 | AstraZenecaINDUSTRY | 8 | Aug 10, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT01157013 | Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma | completed | N/A | 40 | Hospital Miguel ServetOTHER | 1 | Jul 5, 2010 | clinicaltrials |
| NCT01124526 | Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma | completed | Phase 4 | 75 | Asociacion Espanola de Hematologia y HemoterapiaOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00219973 | CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) | completed | Phase 3 | 526 | Rovi Pharmaceuticals LaboratoriesINDUSTRY | 4 | Apr 28, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00646165 | Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia | terminated | Phase 1 | 1 | Mundipharma Research LimitedINDUSTRY | 1 | Mar 31, 2010 | clinicaltrials |
| NCT00303927 | Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene | completed | Phase 2 | 65 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Mar 19, 2010 | clinicaltrials |
| NCT00390715 | Treatment of Acute Myeloblastic Leukemia in Younger Patients | completed | — | 600 | PETHEMA FoundationOTHER | 1 | Mar 15, 2010 | clinicaltrials |
| NCT00099879 | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 7 | Mar 2, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00207012 | MAD Refractory: Solid Tumor QD w/o Break | completed | Phase 1 | 45 | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00359450 | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) | terminated | Phase 2 | 186 | Bristol-Myers SquibbINDUSTRY | 8 | Mar 2, 2010 | clinicaltrials |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | completed | Phase 3 | 485 | PfizerINDUSTRY | 13 | Feb 18, 2010 | clinicaltrials |
| NCT00174772 | Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 72 | SanofiINDUSTRY | 8 | Feb 17, 2010 | clinicaltrials |
| NCT01066429 | DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma | unknown | Phase 2 | 30 | Hospital Universitario Principe de AsturiasOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00002851 | Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed | unknown | Phase 3 | 4,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jan 29, 2010 | clinicaltrials |
| NCT00083889 | SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 750 | PfizerINDUSTRY | 11 | Jan 26, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT00464217 | Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00526305 | LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00865488 | Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery | suspended | Phase 3 | 80 | OMRIX BiopharmaceuticalsINDUSTRY | 5 | Dec 23, 2009 | clinicaltrials |
| NCT00174616 | CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision | completed | Phase 2 | 87 | SanofiINDUSTRY | 7 | Dec 7, 2009 | clinicaltrials |
| NCT00174629 | GILT Docetaxel - Non-Small Cell Lung Cancer | completed | Phase 3 | 449 | SanofiINDUSTRY | 3 | Dec 7, 2009 | clinicaltrials |
| NCT00258739 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials